WT
RMD icon

Washington Trust’s ResMed RMD Stock Holding History

Washington Trust’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-600
Closed -$146K – 883
2024
Q3 		$146K Hold
600
– – 0.01% 311
2024
Q2 		$115K Hold
600
– – ﹤0.01% 330
2024
Q1 		$119K Hold
600
– – ﹤0.01% 334
2023
Q4 		$103K Hold
600
– – ﹤0.01% 330
2023
Q3 		$88.7K Hold
600
– – ﹤0.01% 324
2023
Q2 		$131K Hold
600
– – 0.01% 293
2023
Q1 		$131K Hold
600
– – 0.01% 297
2022
Q4 		$125K Hold
600
– – 0.01% 294
2022
Q3 		$131K Hold
600
– – 0.01% 276
2022
Q2 		$126K Hold
600
– – 0.01% 289
2022
Q1 		$146K Buy
+600
New +$145K 0.01% 293
2021
Q4 		– Sell
-137,569
Closed -$36.3M – 1062
2021
Q3 		$36.3M Sell
137,569
-1,639
-1% -$448K 1.02% 28
2021
Q2 		$34.3M Buy
139,208
+66
+0% +$13.9K 0.97% 30
2021
Q1 		$27M Buy
139,142
+1,427
+1% +$286K 0.83% 38
2020
Q4 		$29.3M Buy
137,715
+115
+0.1% +$22.9K 0.94% 28
2020
Q3 		$23.6M Sell
137,600
-8,655
-6% -$1.6M 0.87% 32
2020
Q2 		$28.1M Sell
146,255
-11,289
-7% -$1.85M 1.17% 20
2020
Q1 		$23.2M Buy
157,544
+3,531
+2% +$562K 1.11% 25
2019
Q4 		$23.9M Buy
+154,013
New +$22.2M 0.94% 34

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Washington Trust's RMD Position: Q4 2024 in Review

Washington Trust sold out of ResMed (RMD) in Q4 2024, closing a stake of 600 shares — an estimated $146K sold.

Washington Trust first reported a position in RMD in Q4 2019 and held it in 19 quarters. The position peaked at $36.3M in Q3 2021. 871 funds tracked by Wall St. Rank hold RMD as of Q4 2024.

  • Washington Trust reported no remaining ResMed position as of Q4 2024 after selling out during the quarter.
  • Washington Trust sold 600 ResMed shares in Q4 2024, an estimated $146K.
  • Washington Trust first reported a position in ResMed in Q4 2019 and held it in 19 quarters.
  • Washington Trust's ResMed position peaked at $36.3M in Q3 2021.
  • 871 funds tracked by Wall St. Rank held ResMed as of Q4 2024.

Based on Washington Trust's 13F filing for Q4 2024, filed 30 Jan 2025.